These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 2885344

  • 21. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 22. Review of the side-effect profile of buspirone.
    Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ.
    Am J Med; 1986 Mar 31; 80(3B):17-21. PubMed ID: 2870641
    [Abstract] [Full Text] [Related]

  • 23. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS, Young R, Roginsky M.
    J Clin Psychiatry; 1980 Nov 31; 41(11):386-92. PubMed ID: 6108319
    [Abstract] [Full Text] [Related]

  • 24. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
    Lapierre YD.
    Int J Clin Pharmacol Biopharm; 1975 Jun 31; 11(4):315-22. PubMed ID: 239907
    [Abstract] [Full Text] [Related]

  • 25. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB.
    J Clin Psychiatry; 1981 Sep 31; 42(9):347-51. PubMed ID: 6115853
    [Abstract] [Full Text] [Related]

  • 26. Early response and 8-week treatment outcome in GAD.
    Rynn M, Khalid-Khan S, Garcia-Espana JF, Etemad B, Rickels K.
    Depress Anxiety; 2006 Sep 31; 23(8):461-5. PubMed ID: 16845651
    [Abstract] [Full Text] [Related]

  • 27. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
    Uhlenhuth EH.
    J Clin Psychiatry; 1982 Dec 31; 43(12 Pt 2):109-16. PubMed ID: 6130067
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.
    Ross CA, Matas M.
    Can J Psychiatry; 1987 Jun 31; 32(5):351-5. PubMed ID: 3308052
    [Abstract] [Full Text] [Related]

  • 33. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K.
    J Clin Psychiatry; 1983 Nov 31; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP.
    J Clin Psychiatry; 1987 Dec 31; 48 Suppl():3-6. PubMed ID: 3320034
    [Abstract] [Full Text] [Related]

  • 38. Buspirone--a new antianxiety agent not chemically related to any presently marketed drugs [proceedings].
    Goldberg HL.
    Psychopharmacol Bull; 1979 Apr 31; 15(2):90-2. PubMed ID: 34846
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.
    J Clin Psychiatry; 1990 Sep 31; 51 Suppl():31-9. PubMed ID: 2211564
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep 31; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.